Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Benefits and Harms of CT Screening for Lung Cancer
1.248
Zitationen
15
Autoren
2012
Jahr
Abstract
Low-dose computed tomography screening may benefit individuals at an increased risk for lung cancer, but uncertainty exists about the potential harms of screening and the generalizability of results.
Ähnliche Arbeiten
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 · 15.793 Zit.
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 · 11.470 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.863 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 9.979 Zit.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
2015 · 9.414 Zit.
Autoren
Institutionen
- Memorial Sloan Kettering Cancer Center(US)
- SUNY Downstate Health Sciences University(US)
- American Society of Clinical Oncology(US)
- The University of Texas MD Anderson Cancer Center(US)
- Emory University(US)
- Colorado School of Public Health(US)
- Washington University in St. Louis(US)
- Kaiser Permanente(US)
- University of Colorado Denver(US)
- Baylor College of Medicine(US)
- University of California, San Francisco(US)
- University of Washington(US)
- American Board of Internal Medicine(US)
- Yale University(US)